Source MS Society:
People with the most common form of multiple sclerosis should be offered drug treatment earlier, a charity says.
The Multiple Sclerosis Society’s report suggests there is a “wait-and-see” approach by doctors which needs to end.
But drug watchdog NICE says while this “disease-modifying therapy” can help in some cases, the benefits need to be weighed carefully against side-effects. Read on.